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nificant trend towards lower rate of ISR and MACE com-
pared with bare metal stents mainly due to more repeat
revascularizations in the bare metal stent group.
http://dx.doi:10.1016/j.jsha.2012.06.242
P wave dispersion as a valuable marker in pre-
diction of outcome of tricuspid regurgitation and
improved right ventricular function after percuta-
neous balloon mitarl valvuloplasty in patients
with mitral stenosis
Ragab A. Mahfouz, Mohamed El Tahlawi, A. Shraf
Dewedar
Objective: To investigate the impact of P-wave dis-
persion (PWD) outcome of tricuspid regurgitation (TR)
and right ventricular (RV) function after successful per-
cutaneous mitral balloon valvuloplasty (PMBV) in
patients with mitral stenosis (MS) and sinus rhythm.
Methods: Seventy-eight consecutive patients under-
going PMBV were enrolled in this study.
We evaluated PWD before and 1 month after PBMV.
We studied the TR severity and RV function, in addition
to the changes in pulmonary artery pressure (PAP), left
atrial (LA) dimension, mitral diastolic gradient, and
mitral valve area, the changes before and after PMBV.
Results: Patients with TR regression and improved
RV function were classified as group A and those without
regression of TR were classified as group B. There were
significant decreases in mean diastolic gradient, PAP,
and LA size, significant regression of TR from moder-
ate-severe TR to mild TR and improvement in RV func-
tion after PMBV. PWD significantly decreased
(P < 0.001). Group B patients during follow-up had a
higher PWD than those in group A (P < 0.001). It was
revealed with linear regression and correlation analysis
that the degree of changes in PWD were correlated with
development of regression of TR and improved RV fun-
cion after PMBV.
Conclusion: P-wave maximum and dispersion are
significantly increased in patients with MS. They
decreased significantly after PMBV. They were signifi-
cantly correlated with TR severity and impairment of
right ventricular function and the degree of PAP. P max-
imum and dispersion could be considered as indepen-
dent predictors of TR regression and improved RV
functionin patients with MS after PMBV.
http://dx.doi:10.1016/j.jsha.2012.06.243
Long-term outcomes of acute coronary syndrome
in young adults: Findings from Gulf RACE-2
M. Al-Mohammadi, A. Hersi, K.F. Alhabib, A.A.
Alsheikh-Ali, K. Sulaiman, H. Alfaleh, S. Alsaif, W.
Almahmeed, N. Asaad, H. Amin, A. Al-Motarreb, J.
Al Suwaidi
Background: Long term outcome of young patients
presenting with acute coronary syndrome (ACS) has
not been described in the Middle East.
Objectives: To evaluate the risk factors, presenta-
tions, clinical assessments and long term outcome of
young patients as compared with older patients with
acute coronary syndrome.
Methods: The multi-center, prospective Arabian
Gulf Registry of Acute Coronary Events (Gulf RACE-2)
was used to determine the long term outcome of young
patients with ACS.
Results: Sixty-five hospitals in 6 Arabian Gulf coun-
tries enrolled 7930ACS patients fromOctober 2008 to June
2009. Patients were divided in to two groups. Group A
640 years, 686 pts (8.7%) with mean age of 36 ± 4 years
and Group B >40 years, 7244 pts (91.3%). Group A had a
higher prevalence of STEMI (62% vs. 42.9%; P < 0.001),
male gender (91.3% vs. 77.6%; P < 0.001), smoking (61.5%
vs. 33.2%; P < 0.001) and a lower prevalence of diabetes
(18% vs. 42.2%; P < 0.001), hypertension (21.4% vs. 50.2%;
P < 0.001) and hyperlipidemia (22% vs. 38.9%; P < 0.001)
as compared to Group B. However, in-hospital, 30 days
and1-yearmortality ratewere significantly lower inGroup
AcomparedwithGroupB (1.9%vs. 4.8%, 4.4%vs. 8.5%and
5.7% vs. 13.2%, respectively; P < 0.001 for all comparisons).
Conclusion: ACS among young adults is a major
concern. There is a need for prevention programs to con-
trol smoking epidemic by targeting young adults in the
population. Our study documented for the first time long
term outcome among young patients with ACS in the
Middle East.
http://dx.doi:10.1016/j.jsha.2012.06.244
The ECG role in identifying the etiology of
tachycardia-induced cardiomyopathy (TIC)
M. Almehairi, S. Algamdi, K. Dagriri, A. Alfagih
Tachycardia-induced cardiomyopathy (TIC) is a well
recognized entity of heart failure (HF) and variousmecha-
nisms due to tachyarrhythmias have been postulated to be
responsible for impaired cardiac contractility. Previously
reported cases showed reversibility of such disorder
whenever stable cardiac rhythm ismaintained adequately
and we report on a 16-year-old boy who has been diag-
nosed to have TIC, which was misinterpreted initially as
sinus tachycardia secondary to dilated cardiomyopathy
and heart failure. A complete recovery of his left ventricu-
lar functionwas achievedby radiofrequency catheter abla-
tion and highlights the importance of a 12-lead
electrocardiogram (ECG) assessment in such patients.
1. Case:
A 16-year-old boy, with a six-month history of







J Saudi Heart Assoc
2012;24:271–304
23RD ANNUAL INTERNATIONAL CONFERENCE 291
hospital for medical management and possible
device implantation. On presentation to our hospi-
tal he was quite symptomatic and had a significant
history of shortness of breath (SOB) at rest, orthop-
nea and paroxysmal nocturnal dyspnea (PND).
He had no evident history of any preceding viral
infection, drugs or alcohol addiction that could be
elicited. An electrocardiogram (ECG) showed non-
sinus tachycardia, with a rate of 160 beats/min,
and an inverted P-wave was noted at lead I, aVL,
and upright P-waves at the inferior leads, sugges-
tive of left atrial automatic focus (Fig. 1).
Despite optimal medical therapy for heart failure
at the time of admission, his echocardiography
revealed a severely dilated left ventricle with ejec-
tion fraction of 15% and severe functional mitral
regurgitation.
Based on our ECG findings which are consistent
with ectopic atrial arrhythmia and amenable for
radiofrequency catheter ablation (RFCA), he
underwent an electrophysiological study (EPS).
An incessant form of left atrial tachycardia was
detected during the study and a non-contact map-
ping system (NAV-X-Endocardial Solutions, Inc.
(ESI), St. Paul, Minnesota) used to identify the
focus. A left atrial geometry was created, and thor-
ough mapping was carried out using both Local
activation and voltage mapping in reference to
the coronary sinus (CS) catheter (Fig. 2). The area
of interest was preceding CS catheter by 58 ms,
adjacent to the left superior pulmonary vein, and
a total of 10 min and 35 s of radiofrequency energy
was applied (50 W, temperature of 60 C.
A complete recovery of sinus rhythm was
achieved afterwards and his heart rate immediately
reduced to 120 beats/min (Fig. 3). A significant
functional capacity and general well being
improvement were documented during follow up
and, with the help of anti-failure medications; car-
diac function recovery was demonstrated by serial
echocardiograms within six months of follow up.
2. Discussion:
Tachycardia-induced cardiomyopathy is a well
described disorder that is related to various types
of arrhythmias [1,2]. Although atrial fibrillation is
the most frequent cause of ventricular dysfunction
in adult age group, it may also be a consequence
rather than a cause of heart failure [3,4]. Unex-
plained systolic dysfunction is associated with any
form of tachyarrhythmias, especially in a normally
structural heart, and should be evaluated carefully.
Many mechanisms have been demonstrated in the
experimental animal models to elucidate the path-
ophysiology of TIC at the level of myocytes.
Unmatched myocardial demand as well as stiff-
ened coronaries secondary to increased sympa-
thetic tone could result in stunning phenomena
[5,7]. Down regulation of beta-1-receptors [6,12],
secondary to myocardial remodeling and depletion
of energy stores [11] with consequent mishandling
of calcium metabolism can impact the myocardial
contractility [7,8,13]. Oxidative stress with an imbal-
ance between pro-oxidant and antioxidant path-
ways was also found to be another co-factor in
the same process of TIC [9,14]. Various changes as
a consequence of the afore-mentioned mechanisms
described histologically are such as myocyte hyper-
plasia and lengthening, myocardial fibrosis,
impaired coronary reserve and apoptosis [10].
The diagnosis of tachycardia-induced cardiomy-
opathy requires a high index of suspicion, as the
underlying arrhythmia may not always be appar-
ent. The paroxysmal nature of the events may
obscure immediate diagnosis of abnormal arrhyth-
mias as a cause of dilated heart. Similarly, a right-
sided atrial ectopic tachycardia in a young patient
is commonly misinterpreted as sinus tachycardia.
The tendency for ectopic foci in young patients to
cluster near atrial appendages or pulmonary veins
and crista terminals may render such rhythm indis-
tinguishable from normal sinus rhythm [15]. In
addition, P-wave morphology can distort the pre-
ceding QRS complex or T wave. Several studies
has been published and focused on 12-lead analy-
sis of P-wave morphology to determine the origin
of the tachycardia. Leads aVL and V1 are the most
useful to distinguish between right and left origin
[16]. Right appendage foci produces a normal fron-
tal plane P-wave axis, but the vector of atrial depo-
larization in the horizontal plane is directed from
anterior to posterior such that the P-wave in the
right chest leads is predominantly negative. Left-
sided foci in the appendage and the left pulmonary
vein are usually quite obvious from the frontal
plane, where the P-wave axis can be typically in
the range of +90 to +180 degree. When it originates
around the crista terminals or right pulmonary
veins, the P-wave can be hard to distinguish from
sinus tachycardia, and other features of the ECG
must be examined with great care [15,16].
In our patient a firm diagnosis of left atrial tachy-
cardia was made on the basis of a standard 12-lead
ECG finding, which reveals a single abnormal P-
wave axis and inappropriate heart rate for the
patient’s age, which was out of proportion to com-
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3. Conclusion:
Recent advances in mapping and ablation of
focal tachycardia provide a safe and successful
curative therapy. However, recognition of such
tachycardia is the key factor for successful manage-
ment. A standard 12-lead surface ECG provides a
simple and non-invasive method that can help in
determining the origin of tachycardia.
Figure 1. Pre-ablation twelve leads electrocardio-
gram showed left atrial tachycardia, rate of
160 beats/min, note the inverted P wave at lead I,
aVL, and upright P-waves at inferior leads and V1.
Figure 2. Three dimensional left atrial geometry
by non-contact mapping system (NAV-X-Endocar-
dial Solutions, Inc. (ESI), St. Paul, Minnesota)
showed the atrial tachycardia focus adjacent to
the left superior pulmonary vein.
Figure 3. Post ablation twelve leads electrocardio-
gram showed sinus tachycardia rate of 120 beat/min.
Note the normalization of the P-wave axis.
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Drug eluted balloon has the potential to treat in-
stent restenosis and small vessels disease
M. Balghith, A. Alghamdi, K. Ayoub, B. Saeed
Background: In-stent restenosis still a major prob-
lem after percutanous coronary intervention. One-quar-
ter of DESs can result in restenosis, paclitaxel-coated
coronary balloons showed an advantage in patients with
in-stent restenosis in different clinical studies, small ves-
sels disease is a challenge in coronary intervention
Methods: Single center study in our cath lab
between Jan 2010–Oct 2011, a total of 36 patients, with
either in-stent restenosis more than 50%, or small vessel
disease, under went balloon angioplasty using a Dior
Eurocor, Drug Eluted Balloon to treat those lesions.
And patients were prepared in the same way of regular
PCI, given heparin and clopidogrel loading and mainte-
nance dose accordingly. We are planning to f/u the
patients clinically for 6 months to 2 years.
Results: Total of 36 patients, 10 (28%) patients had
in-stent restenosis treated by DEB. 26 (72%) patients
had a small vessels disease, diameter <2.5 mm treated
with DEB and balloon size range from 2.0 to 2.25 mm.
The incidence of diabetes mellitus was 70%. Hyperten-
sion 67%. Majority of patients are male patients (26).
The disease was involving all vessels including RCA,
PDA, LAD/DIAG, LCX/OM. Since we started this tech-
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